Murae Organisor Ltd Stock Price Today (NSE: MURAE)
Fundamental Score
Murae Organisor Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Murae Organisor Ltd share price today is ₹0.19, up +0.00% on NSE/BSE as of 22 September 2026. Murae Organisor Ltd (MURAE) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹57.26 (Cr). The 52-week high for MURAE share price is ₹0.67 and the 52-week low is ₹0.19. At a P/E ratio of 3.77x, MURAE is currently trading below its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 5.69% and a debt-to-equity ratio of 1.02.
Murae Organisor Ltd Share Price Chart — NSE/BSE Historical Performance
Murae Organisor Ltd share price chart: 0.00% return over the past month. 52-week high ₹0.67, 52-week low ₹0.19.
Murae Organisor Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹0.19 | ₹0.19 | ₹0.19 | ₹0.19 | 0.00 (Cr) | |
| ₹0.19 | ₹0.19 | ₹0.19 | ₹0.19 | 0.00 (Cr) | |
| ₹0.19 | ₹0.19 | ₹0.19 | ₹0.19 | 0.00 (Cr) | |
| ₹0.19 | ₹0.19 | ₹0.19 | ₹0.19 | 0.00 (Cr) | |
| ₹0.19 | ₹0.19 | ₹0.19 | ₹0.19 | 0.00 (Cr) | |
| ₹0.19 | ₹0.19 | ₹0.19 | ₹0.19 | 0.00 (Cr) | |
| ₹0.19 | ₹0.19 | ₹0.19 | ₹0.19 | 0.00 (Cr) | |
| ₹0.19 | ₹0.19 | ₹0.19 | ₹0.19 | 0.00 (Cr) | |
| ₹0.19 | ₹0.19 | ₹0.19 | ₹0.19 | 0.00 (Cr) | |
| ₹0.19 | ₹0.19 | ₹0.19 | ₹0.19 | 0.00 (Cr) |
Murae Organisor Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹0.19 | ₹0.19 | ₹0.19 | ₹0.19 | +0.00% | |
| ₹0.19 | ₹0.19 | ₹0.19 | ₹0.19 | +0.00% | |
| ₹0.19 | ₹0.19 | ₹0.19 | ₹0.19 | +0.00% | |
| ₹0.19 | ₹0.19 | ₹0.19 | ₹0.19 | +0.00% | |
| ₹0.19 | ₹0.19 | ₹0.19 | ₹0.19 | +0.00% | |
| ₹0.21 | ₹0.22 | ₹0.19 | ₹0.19 | -9.52% | |
| ₹0.21 | ₹0.27 | ₹0.20 | ₹0.22 | +4.76% | |
| ₹0.26 | ₹0.28 | ₹0.20 | ₹0.20 | -23.08% | |
| ₹0.28 | ₹0.31 | ₹0.24 | ₹0.26 | -7.14% | |
| ₹0.26 | ₹0.32 | ₹0.26 | ₹0.28 | +7.69% | |
| ₹0.55 | ₹0.55 | ₹0.27 | ₹0.27 | -50.91% | |
| ₹0.64 | ₹0.67 | ₹0.56 | ₹0.57 | -10.94% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Murae Organisor Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Murae Organisor Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of MURAE across key market metrics for learning purposes.
Positive Indicators
7 factors identified
Attractive Valuation (P/E: 3.77 vs Industry: 31.77)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (3200.00%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (1634.78%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (73.03% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (32.81% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Healthy Liquidity Position (Current Ratio: 2.83)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
7 factors identified
Below-Average Return on Equity (5.69%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (4.20%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (-0.18%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Elevated Debt Levels (D/E: 1.02)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.
Negative Free Cash Flow (₹-343.64 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Low Promoter Commitment (0.00%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Murae Organisor Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Murae Organisor Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Murae Organisor LtdMurae Organisor...Selected✓ MURAE • 542724 | 47.4/100 | ₹0.19₹0 | ₹57.26₹57.26 | 3.77Average 3.8 Average | 5.69%Poor 5.69% Poor | 4.20%Poor 4.20% Poor | 1.02Average 1.0 Average | 32.81%Excellent 32.81% Excellent | 73.03%Excellent 73.03% Excellent | 0.00% |
Sun Pharmaceutical Industries LimitedSun Pharmaceuti... SUNPHARMA • 524715 | 66.4/100 | ₹1864.90₹1865 | ₹447445.46₹447445.46 | 37.00Average 37.0 Average | 14.74%Average 14.74% Average | 19.31%Good 19.31% Good | 0.05Excellent 0.0 Excellent | 31.64%Excellent 31.64% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divi's Laboratories LimitedDivi's Laborato... DIVISLAB • 532488 | 56.3/100 | ₹9488.00₹9488 | ₹251432.00₹251432.00 | 86.09Average 86.1 Average | 16.19%Good 16.19% Good | 20.38%Excellent 20.38% Excellent | 0.00Excellent 0.0 Excellent | 5.29%Good 5.29% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LimitedTorrent Pharmac... TORNTPHARM • 500420 | 51.4/100 | ₹4930.00₹4930 | ₹166860.78₹166860.78 | 78.75Average 78.8 Average | 27.07%Excellent 27.07% Excellent | 14.09%Average 14.09% Average | 1.76Average 1.8 Average | 11.56%Good 11.56% Good | 11.80%Good 11.80% Good | 0.76% |
Zydus Lifesciences LimitedZydus Lifescien... ZYDUSLIFE • 532321 | 74.1/100 | ₹1127.40₹1127 | ₹112514.52₹112514.52 | 25.13Average 25.1 Average | 19.74%Good 19.74% Good | 21.77%Excellent 21.77% Excellent | 0.43Excellent 0.4 Excellent | 18.76%Excellent 18.76% Excellent | 12.45%Good 12.45% Good | 0.09% |
Cipla LimitedCipla Limited... CIPLA • 500087 | 40.2/100 | ₹1363.10₹1363 | ₹110118.03₹110118.03 | 32.66Average 32.7 Average | 11.82%Average 11.82% Average | 15.67%Good 15.67% Good | 0.01Excellent 0.0 Excellent | 10.03%Good 10.03% Good | 8.01%Good 8.01% Good | 0.90% |
Laurus Labs LimitedLaurus Labs Lim... LAURUSLABS • 540222 | 34.1/100 | ₹1937.00₹1937 | ₹104646.43₹104646.43 | 95.61Average 95.6 Average | 18.19%Good 18.19% Good | 21.35%Excellent 21.35% Excellent | 0.45Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Aurobindo Pharma LimitedAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1698.90₹1699 | ₹97754.71₹97754.71 | 26.55Average 26.5 Average | 9.94%Poor 9.94% Poor | 14.54%Average 14.54% Average | 0.20Excellent 0.2 Excellent | -8.07%Poor -8.07% Poor | 6.32%Good 6.32% Good | 0.26% |
Lupin LimitedLupin Limited... LUPIN • 500257 | 83.4/100 | ₹2100.00₹2100 | ₹96022.50₹96022.50 | 17.35Average 17.4 Average | 26.90%Excellent 26.90% Excellent | 31.80%Excellent 31.80% Excellent | 0.26Excellent 0.3 Excellent | 34.39%Excellent 34.39% Excellent | 13.02%Good 13.02% Good | 0.72% |
Dr. Reddy's Laboratories LimitedDr. Reddy's Lab... DRREDDY • 500124 | 41/100 | ₹1145.00₹1145 | ₹95607.50₹95607.50 | 29.59Average 29.6 Average | 11.75%Average 11.75% Average | 14.80%Average 14.80% Average | 0.17Excellent 0.2 Excellent | 16.54%Excellent 16.54% Excellent | 12.09%Good 12.09% Good | 0.65% |
Mankind Pharma LimitedMankind Pharma ... MANKIND • 543904 | 61.5/100 | ₹2265.00₹2265 | ₹93544.50₹93544.50 | 45.77Average 45.8 Average | 12.49%Average 12.49% Average | 13.56%Average 13.56% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Limited share price447445.46 Cr
- Divi's Laboratories Limited share price251432.00 Cr
- Torrent Pharmaceuticals Limited share price166860.78 Cr
- Zydus Lifesciences Limited share price112514.52 Cr
- Cipla Limited share price110118.03 Cr
Murae Organisor Ltd PE Ratio History
Historical price-to-earnings ratio for MURAE — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2023 | ₹0.31 | ₹0.52 | 1.7x |
| FY 2022 | ₹0.30 | ₹1.33 | 4.5x |
| FY 2021 | ₹0.01 | ₹4.59 | 794x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Murae Organisor Ltd Quarterly Performance
Latest quarterly metrics for MURAE — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
1634.78%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
3200.00%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
73.03%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
32.81%
Compounded annual net profit growth over 5 years
Murae Organisor Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for MURAE — calculated from daily price history
Momentum is strong — price may be stretched. Watch for pullbacks.
Technical indicators are for educational purposes only. Not investment advice.
Murae Organisor Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Murae Organisor Ltd (MURAE) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Murae Organisor Ltd
About MURAE (Murae Organisor Ltd)
Murae Organisor Ltd (MURAE) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Pharmaceuticals sector with a curre...nt market capitalisation of ₹57.26 (Cr). Murae Organisor Ltd has delivered a Return on Equity (ROE) of 5.69% and a ROCE of 4.20%. The debt-to-equity ratio stands at 1.02, reflecting the company's capital structure. Investors tracking MURAE share price can monitor key metrics including P/E ratio, promoter holding of 0.00%, and quarterly earnings growth.
Company Details
Key Leadership
MURAE Share Price: Frequently Asked Questions
What is the current share price of Murae Organisor Ltd?
Murae Organisor Ltd (MURAE) trades at ₹0.19 on NSE and BSE. Market cap ₹57.26 (Cr). Educational data only.
What is the P/E ratio of Murae Organisor Ltd?
Murae Organisor Ltd has a P/E of 3.77x vs industry average 31.77x.
What is the Bull Run score for Murae Organisor Ltd?
Murae Organisor Ltd has a Bull Run score of 47.4/100 based on 25+ financial parameters.
Does Murae Organisor Ltd pay dividends?
Murae Organisor Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Murae Organisor Ltd?
Murae Organisor Ltd has ROE of 5.69%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Murae Organisor Ltd?
Murae Organisor Ltd has debt-to-equity of 1.02.
Is Murae Organisor Ltd a good investment?
Bull Run gives Murae Organisor Ltd a score of 47.4/100. This is not investment advice — consult a SEBI-registered advisor.